Studies demonstrate that elevated NLR serves as a marker of poor prognosis in both TNBC and HER2-positive breast cancer, with increasing ratios correlating with heightened mortality risk in breast cancer patients (117). This evidence concerns the gene ERBB2 and breast carcinoma.